Strain-Specific Neutralization of Human Cytomegalovirus Isolates by Human Sera

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Virology

• Publication date

  1999-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.73.2.878-886.1999PMID 9882288PMCID PMC103907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies.

  1997influential reference
• The role of antibody concentration and avidity in antiviral protection.

  1997cited by this paper
• Human cytomegalovirus glycoproteins.

  1996cited by this paper
• Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS.

  1996cited by this paper
• Current prospects for immunization against cytomegaloviral disease.

  1996cited by this paper
• Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response.

  1996cited by this paper
• Altered expression of host‐encoded complement regulators on human cytomegalovirus‐infected cells

  1996cited by this paper
• Current prospects for immunization against cytomegaloviral disease.

  1996cited by this paper
• Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age.

  1995cited by this paper
• Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).

  1995cited by this paper
• The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease

  1994cited by this paper
• Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients.

  1994cited by this paper
• Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus

  1994cited by this paper
• Prevention and treatment of cytomegalovirus pneumonia in transplant recipients.

  1993cited by this paper
• The Human Herpesviruses

  1993cited by this paper
• Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus

  1992cited by this paper
• Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus.

  1992cited by this paper
• The outcome of congenital cytomegalovirus infection in relation to maternal antibody status

  1992cited by this paper
• Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies.

  1992cited by this paper
• The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific

  1992influential reference
• Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.

  1992cited by this paper
• Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies.

  1991cited by this paper
• Comparative sequence analysis of human cytomegalovirus strains

  1991cited by this paper
• Prevention of cytomegalovirus-associated diseases with immunoglobulin.

  1991cited by this paper
• Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes.

  1991cited by this paper
• Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response

  1990cited by this paper
• Characterization of human anti-cytomegalovirus monoclonal antibody as biologics.

  1990influential reference
• Vaccines for the prevention of human cytomegalovirus infection.

  1990cited by this paper
• Multiplicity dependent expression of the predominant phosphoprotein pp65 of human cytomegalovirus.

  1989cited by this paper
• Complement‐Independent neutralising monoclonal antibody with differential reactivity for strains of human cytomegalovirus

  1989cited by this paper
• A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus.

  1989cited by this paper
• Neutralizing antibody responses to reinfecting strains of cytomegalovirus in transplant recipients.

  1989cited by this paper
• A prospective molecular epidemiological study of cytomegalovirus infections in two day care centers in Sweden: no evidence for horizontal transmission within the centers.

  1988cited by this paper
• Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus.

  1988cited by this paper
• Rhesus Monkey Responses to Multiple Injections of Human Monoclonal Antibodies

  1987cited by this paper
• Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins.

  1987cited by this paper
• Human monoclonal antibodies neutralizing human cytomegalovirus.

  1987cited by this paper
• Comparison of restriction site polymorphisms among clinical isolates and laboratory strains of human cytomegalovirus.

  1986cited by this paper
• Comparison of the Neutralizing and ELISA Antibody Titres to Human Cytomegalovirus (HCMV) in Human Sera and in Gamma Globulin Preparations

  1986cited by this paper
• Poliovirus neutralization and the percentage law. Brief report.

  1985cited by this paper
• Identification of a 65 000 dalton virion envelope protein of human cytomegalovirus.

  1985cited by this paper
• Murine monoclonal antibody to a single protein neutralizes the infectivity of human cytomegalovirus.

  1984cited by this paper
• Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus.

  1983cited by this paper
• Cytomegalovirus: Biology and Infection

  1983cited by this paper
• Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection.

  1982cited by this paper
• Herpesvirus morphology: visualization of a structural subunit.

  1978cited by this paper
• Antigenic relatedness of 17 strains of human cytomegalovirus.

  1978cited by this paper
• Analysis of antigenic diversity among human cytomegaloviruses by kinetic neutralization tests with high-titered rabbit antisera

  1978cited by this paper
• Analysis of cytomegalovirus genomes with restriction endonucleases Hin D III and EcoR-1

  1976cited by this paper
• SMALL-INTESTINAL HISTOLOGY IN CŒLIAC DISEASE

  1975cited by this paper
• Observations on Anti-Phage Sera. I: “The Percentage Law”

  1933cited by this paper
• THE CHARTER OF THE ROYAL COLLEGE OF SURGEONS IN LONDON.

  1824cited by this paper

• Evaluation of a Reverse Transcription-Quantitative Polymerase Chain Reaction (RT-qPCR)-Based Microneutralization Assay for Assessing Clinical Human Cytomegalovirus-Neutralizing Antibody Activity

  2024cites this paper
• Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection

  2023cites this paper
• Fibroblast, Epithelial and Endothelial Cell-Derived Human Cytomegalovirus Strains Display Distinct Neutralizing Antibody Responses and Varying Levels of gH/gL Complexes

  2023cites this paper
• Human cytomegalovirus strain diversity and dynamics reveal the donor lung as a major contributor after transplantation

  2022cites this paper
• Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity

  2021cites this paper
• Pathogenesis of Wild-Type-Like Rhesus Cytomegalovirus Strains following Oral Exposure of Immune-Competent Rhesus Macaques

  2021cites this paper
• Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection

  2020cites this paper
• A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection

  2019cites this paper
• Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades’ résumé

  2019cites this paper
• Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantation

  2019cites this paper
• Human cytomegalovirus evades antibody-mediated immunity through endoplasmic reticulum-associated degradation of the FcRn receptor

  2019cites this paper
• A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection

  2018cites this paper
• Recombinant cytomegalovirus glycoprotein B vaccine: Rethinking the immunological basis of protection

  2018cites this paper
• The role of viral and immunological factors in congenital cytomegalovirus infections

  2018cites this paper
• Investigating the role of human cytomegalovirus protein LUNA in regulating viral gene expression during latency

  2018cites this paper
• Development and optimization of virus neutralization test in chicken embryonated eggs for indirect identification of avian influenza and Newcastle disease virus

  2018cites this paper
• Genetic signatures of human cytomegalovirus variants acquired by seronegative glycoprotein B vaccinees

  2018cites this paper
• Defining the Role of Antibodies in Protection Against Cytomegalovirus Acquisition and Congenital Disease for Rational Vaccine Design

  2018cites this paper
• The Incidence of Cytomegalovirus Glycoprotein B Genotypes in Kidney Transplant Recipients in Iran

  2018cites this paper
• Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees

  2018cites this paper
• Analysis of relationships between polymorphisms in the genes encoding the pentameric complex and neutralization of clinical cytomegalovirus isolates.

  2018cites this paper
• A two‐step screening approach for the identification of blood donors with highly and broadly neutralizing capacities against human cytomegalovirus

  2017cites this paper
• Title Reinfection of cytomegalovirus in renal transplantation

  2017cites this paper
• Co-delivery of GPI-anchored CCL28 and influenza HA in chimeric virus-like particles induces cross-protective immunity against H3N2 viruses.

  2016cites this paper
• Human Cytomegalovirus (HCMV) - Revised*

  2016cites this paper
• Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway

  2016cites this paper
• Molecular characterization of HCMV‐specific immune responses: Parallels between CD8+ T cells, CD4+ T cells, and NK cells

  2015cites this paper
• Complete Protection of Mice against Lethal Murine Cytomegalovirus Challenge by Immunization with DNA Vaccines Encoding Envelope Glycoprotein Complex III Antigens gH, gL and gO

  2015cites this paper
• Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection

  2014cites this paper
• Anti-Cytomegalovirus Antibodies To Measure the Neutralization Capability of Development of a High-Throughput Assay

  2014cites this paper
• Viral Diversity and Neutralizing Antibody Responses in Infants with Symptomatic Congenital CMV Disease receiving Antiviral Therapy

  2014cites this paper
• Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases

  2013cites this paper
• Development of a High-Throughput Assay To Measure the Neutralization Capability of Anti-Cytomegalovirus Antibodies

  2013cites this paper
• Cytomegalovirus (CMV) glycoprotein H-based serological analysis in Japanese healthy pregnant women, and in neonates with congenital CMV infection and their mothers.

  2013cites this paper
• Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies

  2012cites this paper
• 9 Role of Cytomegalovirus Reinfection in Acute Rejection and CMV Disease After Renal Transplantation

  2012cites this paper
• Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines

  2012cites this paper
• Role of Cytomegalovirus Reinfection in Acute Rejection and CMV Disease After Renal Transplantation

  2012cites this paper
• 106 CMV Infections

  2012cites this paper
• Renal Transplantation - Updates and Advances

  2012cites this paper
• Strain-Specific Neutralizing Antibody Responses against Human Cytomegalovirus Envelope Glycoprotein N

  2012cites this paper
• Virus-host interaction for defence and transmission

  2011cites this paper
• Human cytomegalovirus: an enormous variety of strains and their possible clinical significance in the human host

  2011cites this paper
• Reinfection of cytomegalovirus in renal transplantation.

  2011cites this paper
• Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus.

  2011influential citation
• Humanes Cytomegalievirus (HCMV). Stellungnahmen des Arbeitskreises Blut des Bundesministeriums für Gesundheit

  2010cites this paper
• Glycoprotein gene sequence variation in rhesus monkey rhadinovirus.

  2010cites this paper
• Human Cytomegalovirus (HCMV) – Revised

  2010cites this paper
• Humanes Cytomegalievirus (HCMV)

  2010cites this paper
• Human cytomegalovirus infection downregulates the expression of glial fibrillary acidic protein in human glioblastoma U373MG cells: identification of viral genes and protein domains involved.

  2009cites this paper
• Association between antibody response against cytomegalovirus strain‐specific glycoprotein H epitopes and HLA‐DR

  2009cites this paper
• Glycoprotein N subtypes of human cytomegalovirus induce a strain-specific antibody response during natural infection.

  2009cites this paper
• Etablierung und Evaluierung eines Mikroneutralisationstests mit Trophoblasten- Primärkulturen zur Abschätzung des HCMV-Transmissionsrisikos bei maternaler Primärinfektion

  2009cites this paper
• Concurrent Genotyping and Quantitation of Cytomegalovirus gB Genotypes in Solid-Organ-Transplant Recipients by Use of a Real-Time PCR Assay

  2008cites this paper
• Strain-specific seroepidemiology and reinfection of cytomegalovirus.

  2008cites this paper
• Novel microneutralization assay for HCMV using automated data collection and analysis

  2007influential citation
• Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes.

  2007cites this paper
• Arbobakterien (über Arthropoden übertragbare Bakterien)

  2007cites this paper
• Vaccine strategies against human cytomegalovirus infection

  2007cites this paper
• Genetic polymorphism of UL144 open reading frame of human cytomegalovirus DNA detected in colon samples from infants with Hirschsprung's disease.

  2007cites this paper
• Genetic Variability of Human Cytomegalovirus UL132 Gene in Strains from Infected Infants

  2006cites this paper
• Chapter 23 – Cytomegalovirus Infections

  2006cites this paper
• Emergence of Multiple Cytomegalovirus Strains in Blood and Lung of Lung Transplant Recipients

  2006cites this paper
• Cytomegalovirus and Varicella–Zoster Virus Vaccines

  2006cites this paper
• Human Cytomegalovirus Infection Elicits a Glycoprotein M (gM)/gN-Specific Virus-Neutralizing Antibody Response

  2006cites this paper
• Human Cytomegalovirus

  2005cites this paper
• Genomic variants among human cytomegalovirus (HCMV) clinical isolates: the glycoprotein n (gN) paradigm.

  2004cites this paper
• Genetic polymorphisms among human cytomegalovirus (HCMV) wild‐type strains

  2004cites this paper
• In-vivo-Untersuchung der Expression der Adhäsionsmoleküle ICAM-1, VCAM-1 und ELAM-1 in HCMV-infiziertem Gewebe

  2004cites this paper
• Entwicklung eines ELISA-basierten Neutralisationstests zur Untersuchung der CMV-spezifischen Immunantwort stammzelltransplantierter Patienten nach adoptivem Immuntransfer

  2004cites this paper
• Activation of Virus-specific Memory B Cells in the Absence of T Cell Help

  2004cites this paper
• Herpesviral Fcγ receptors: culprits attenuating antiviral IgG?

  2004cites this paper
• Mother-to-fetus transmission of cytomegalovirus. A review.

  2004cites this paper
• Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure.

  2003cites this paper
• Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus.

  2003cites this paper
• Human cytomegalovirus glycoprotein N genotypes in AIDS patients.

  2003cites this paper
• The Genes Encoding the gCIII Complex of Human Cytomegalovirus Exist in Highly Diverse Combinations in Clinical Isolates

  2002cites this paper
• Antibody-mediated neutralization of cytomegalovirus: modulation of efficacy induced through the IgG constant region.

  2002cites this paper
• Is there a formula for an effective CMV vaccine?

  2002cites this paper
• Identification of Glycoprotein gpTRL10 as a Structural Component of Human Cytomegalovirus

  2002cites this paper
• Upregulation of CD40 Expression on Endothelial Cells Infected with Human Cytomegalovirus

  2002cites this paper
• Occupancy and mechanism in antibody-mediated neutralization of animal viruses.

  2002cites this paper
• Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection.

  2002cites this paper
• Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy *

  2001cites this paper
• Down-Regulierung von MHC-Klasse-I-Molekülen auf HCMV-infizierten Zellen in vivo

  2001cites this paper
• Development of a cytomegalovirus vaccine: lessons from recent clinical trials

  2001cites this paper
• Human Cytomegalovirus

  2001cites this paper
• gpUL73 (gN) genomic variants of human cytomegalovirus isolates are clustered into four distinct genotypes.

  2001cites this paper
• Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity

  2001cites this paper
• Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.

  2001cites this paper
• Humanes Cytomegalovirus (HCMV) Stellungnahmen des Arbeitskreises Blut des Bundesministeriums für Gesundheit

  2000cites this paper
• Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients

  2000cites this paper
• Human Cytomegalovirus UL144 Open Reading Frame: Sequence Hypervariability in Low-Passage Clinical Isolates

  1999cites this paper
• Constitutive Expression of Human Cytomegalovirus (HCMV) Glycoprotein gpUL75 (gH) in Astrocytoma Cells: A Study of the Specific Humoral Immune Response

  1999cites this paper
• TT virus--part of the normal human flora?

  1999cites this paper
• Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization.

  1999cites this paper
• Neutralizing antibody response against human cytomegalovirus in allogeneic bone marrow-transplant recipients.

  1999cites this paper